# CTTH (Ctt Pharmaceutical Holdings, Inc.) - SEC EDGAR Financial Statements

> Ctt Pharmaceutical Holdings, Inc. reported $78K in total assets and a net loss of $672K through December 31, 2014 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/CTTH
- Markdown: https://convexityos.com/fundamentals/CTTH.md
- SEC CIK: 0001035422
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001035422&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2014 | -- | Dec 31, 2014 |
| Operating Income | FY 2014 | -$672K | Operating profit |
| Net Income | FY 2014 | -$672K | GAAP bottom line |
| Diluted EPS | FY 2014 | $0.01 | Split-adjusted |
| Free Cash Flow | FY 2014 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
| --- | --- | --- | --- | --- | --- |
| Total Operating Expenses | $672K | $19K | $1.19M | $758K | $2.07M |
| **Operating Income** | -$672K | -$19K | -$1.19M | -$758K | -$2.07M |
| **EBITDA** | -- | -- | -- | -$758K | -$2.00M |
| **Net Income** | -$672K | -$19K | -$1.00M | $3.74M | -$1.10M |
| Basic EPS | $0.01 | $0.01 | -$0.11 | $0.42 | -$0.13 |
| **Diluted EPS** | $0.01 | $0.01 | -$0.11 | $0.40 | -$0.13 |
| Basic Shares Outstanding | 163.4M | 9.4M | 9.4M | 8.9M | 8.5M |
| Diluted Shares Outstanding | 163.4M | 9.4M | 9.4M | 9.5M | 8.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Sep 2025 | Sep 2015 | Jun 2015 | Mar 2015 | Dec 2014 | Sep 2014 | Jun 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Total Operating Expenses | $127K | $15K | $342K | $363K | $337K | $629K | $43K | $920 |
| **Operating Income** | -- | -- | -- | -- | -$337K | -- | -- | -$22K |
| Interest Income | $131 | $0 | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$127K | -$15K | -$342K | -$363K | -$337K | -$629K | -$43K | -$920 |
| Basic EPS | -- | -- | -$0.03 | $0.00 | $0.02 | -- | $0.01 | $0.00 |
| **Diluted EPS** | $0.00 | $0.00 | -$0.03 | $0.00 | $0.02 | -- | -$0.01 | $0.00 |
| Basic Shares Outstanding | 60.7M | 57.3M | 21.3M | 213.2M | 195.1M | -- | 15.8M | 22.3M |
| Diluted Shares Outstanding | 60.7M | 57.3M | 21.3M | 213.2M | 195.1M | -- | 15.8M | 22.3M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $81K | $0 | $0 | $569K | $46K |
| Short-Term Investments | -- | $0 | $164K | $0 | -- |
| **Cash & Short-Term Investments** | $81K | $0 | $164K | $569K | $46K |
| Accounts Receivable, Net | $5.4K | $0 | $8.7K | $151 | $166K |
| **Total Current Assets** | $1.05M | $6.3K | $203K | $751K | $520K |
| Property, Plant & Equipment, Net | -- | -- | -- | $0 | $426K |
| **Total Non-Current Assets** | $613K | -$6.3K | $0 | $3.43M | $743K |
| **Total Assets** | $1.66M | $0 | $203K | $4.18M | $1.26M |
| **Total Current Liabilities** | -- | $249K | $589K | $3.73M | $945K |
| **Total Non-Current Liabilities** | -- | -$220K | $0 | $0 | $316K |
| **Total Liabilities** | $169K | $29K | $589K | $3.73M | $1.26M |
| Common Stock | $2.0K | $15K | $19K | $19K | $18K |
| Retained Earnings | -$867K | -$195K | -- | -- | -- |
| Accumulated Other Comp. Income | -$1.1K | -$4.2K | $5.0K | -$106K | -$106K |
| **Total Stockholders' Equity** | $1.49M | -$29K | -$20K | $456K | $1.3K |
| Total Equity | $1.49M | -$29K | -$20K | $456K | $1.3K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Dec 2025 | Sep 2015 | Jun 2015 | Mar 2015 | Dec 2014 | Sep 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | $32K | $46K | $73K | $81K | $125K |
| **Cash & Short-Term Investments** | -- | -- | -- | $32K | $46K | $73K | $81K | $125K |
| Accounts Receivable, Net | -- | -- | -- | $5.4K | $5.4K | $5.4K | $5.4K | $5.4K |
| **Total Current Assets** | $13K | $31 | $15K | $922K | $959K | $1.04M | $1.05M | -- |
| Intangible Assets | $66K | $67K | $71K | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $66K | $67K | $71K | $0 | $225K | $377K | $613K | -- |
| **Total Assets** | $78K | $67K | $86K | $922K | $1.18M | $1.42M | $1.66M | $131K |
| **Total Current Liabilities** | $37K | $41K | $31K | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | -- | -- | -- | -- | -- |
| **Total Liabilities** | $37K | $41K | $31K | $184K | $196K | $1.12M | $169K | $125K |
| Common Stock | $6.2K | $6.0K | $5.9K | $2.1K | $21K | $20K | $2.0K | $18K |
| Retained Earnings | -$7.78M | -$7.65M | -$7.55M | -$1.91M | -$667K | -$304K | -$867K | -$231K |
| Accumulated Other Comp. Income | -- | -- | -- | $3.8K | $1.3K | $2.3K | -$1.1K | -$3.1K |
| **Total Stockholders' Equity** | $41K | $26K | $55K | $738K | $987K | $301K | $1.49M | $6.1K |
| Total Equity | $41K | $26K | $55K | $738K | $987K | $301K | $1.49M | $6.1K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$672K | -$19K | -$1.00M | $3.74M | -$1.10M |
| Depreciation & Amortization | -- | -- | -- | $0 | $70K |
| Stock-Based Compensation | $308K | $0 | $42K | $155K | $154K |
| Change in Receivables | -- | $3.3K | -$8.6K | $0 | -$158K |
| **Operating Cash Flow** | -$72K | -$209 | -$1.03M | -$316K | -$1.67M |
| **Investing Cash Flow** | $152K | $125K | $436K | $877K | $0 |
| Common Stock Issued | -- | -- | -- | $0 | $1.80M |
| **Financing Cash Flow** | -- | $0 | $34K | -$38K | $1.45M |
| **Net Change in Cash** | $81K | -$11K | -$557K | $523K | -$225K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Sep 2025 | Sep 2015 | Jun 2015 | Mar 2015 | Dec 2014 | Sep 2014 | Jun 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$127K | -$15K | -$342K | -$363K | -$337K | -$629K | -$43K | -$920 |
| Stock-Based Compensation | -- | -- | $46K | $49K | $44K | -- | -- | -- |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Operating Cash Flow** | -- | -- | -$16K | -$29K | -$40K | -$47K | -$24K | -$29K |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -$1 | $271K | -$148K |
| **Financing Cash Flow** | -- | -- | -$959 | $2.8K | $29K | -- | -$4.9K | $387K |
| **Net Change in Cash** | -- | -- | -$14K | -$27K | -$7.7K | -$44K | $122K | $210K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
| --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -45.0% | -- | -- | 819.0% | -81554.2% |
| Return on Assets (ROA) | -40.4% | -- | -494.0% | 89.4% | -87.0% |
| Current Ratio | -- | 0.03x | 0.34x | 0.20x | 0.55x |
| Quick Ratio | -- | 0.00x | 0.29x | 0.15x | 0.22x |
| **Net Income Growth (YoY)** | -- | -- | -126.8% | -- | -- |
| EPS Growth (YoY) | 0.0% | -- | -126.2% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Sep 2025 | Sep 2015 | Jun 2015 | Mar 2015 | Dec 2014 | Sep 2014 | Jun 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -226.3% | -139.0% | -335.6% | -45.2% | -866.6% | -21.7% |
| Return on Assets (ROA) | -- | -- | -181.1% | -115.9% | -71.2% | -40.6% | -40.7% | -8.2% |
| Current Ratio | 0.34x | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -400.0% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
